Keata Pharma, a subsidiary of PharmEng International, has signed an agreement with an undisclosed global consumer healthcare company for the manufacture of branded non-prescription drug products for Canada and other international territories. This new agreement replaces an existing sub-contracting relationship between the two companies.     Under the agreement, Keata will supply the products for an initial two-year term beginning January 1, 2009 with an option to extend the agreement for two ...